Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells

Experimental Cell Research

Volumn 312, Issue 15, 2006, Pages 2806-2815

  Kropotov, Andrey ^a,b,c   Gogvadze, Vladimir ^b   Shupliakov, Oleg ^b   Tomilin, Nikolay ^b   Serikov, Vladimir B ^a   Tomilin, Nikolai V ^c   Zhivotovsky, Boris ^b  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

Apoptosis; Mitochondria; Oxidative stress; Peroxiredoxin V

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; CALCIUM; CYTOCHROME C; DOXORUBICIN; ETOPOSIDE; PEROXIREDOXIN; PEROXIREDOXIN V; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL LINE; CELL PROTECTION; CELL SURVIVAL; CORRELATION FUNCTION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG CARCINOMA; MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; REGULATORY MECHANISM;

EID: 33747371086     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.05.006     Document Type: Article

References (48)

1. Mountain C.F. The international system for staging lung cancer. Semin. Surg. Oncol. 18 (2000) 106-115
2. Ames B.N., Shigenaga K.M., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7915-7922
3. Sen C.K., and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10 (1996) 709-720
4. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
5. 2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J. Cell Sci. 111 (1998) 3209-3220
6. Nishida S., Nakano T., Kimoto S., Kusunoki T., Tanigushi N., Murata K., and Tomura T.T. Induction of manganese superoxide dismutase by thyroid stimulating hormone in rat thyroid cells. FEBS Lett. 416 (1997) 69-71
7. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine. 2nd ed. (1998), Oxford Univ. Press, London
8. Hofmann B., Hecht H.-J., and Flohé L. Peroxiredoxins. Biol. Chem. 383 (2002) 347-364
9. Wood Z.A., Poole L.B., and Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300 (2003) 650-653
10. Wood Z.A., Schroder E., Robin H.J., and Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28 (2003) 32-40
11. Rhee S.G., Chang T.S., Bae Y.S., Lee S.R., and Kang S.W. Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol. 14 Suppl. 3 (2003) 211-215
12. Knoops B., Clippe A., Bogard C., Arsalane K., Wattiezi R., Hermans C., Duconseille E., Falmagnei P., and Bernard A. Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the Peroxiredoxin Family. JBC 274 (1999) 30451-30458
13. Kropotov A., Sedova V., Ivanov V., Sazeeva N., Tomilin A., Krutilina R., Oei S.L., Griesenbeck J., Buchlow G., and Tomilin N. A novel human DNA-binding protein with sequence similarity to a subfamily of redox proteins which is able to repress RNA-polymerase-III-driven transcription of the Alu-family retroposons in vitro. Eur. J. Biochem. 260 (1999) 336-346
14. Yamashita H., Avraham S., Jiang S., London R., Van Veldhoven P.P., Subramani S., Rogers R.A., and Avraham H. Characterization of human and murine PMP20 peroxisomal proteins that exhibit antioxidant activity in vitro. JBC 274 (2003) 29897-29904
15. Oberley T.D., Verwiebe E., Zhong W., Kang S.W., and Rhee S.G. Localization of the thioredoxin system in normal rat kidney. Free Radical Biol. Med. 30 (2001) 412-424
16. Seok S.M., Kang S.W., Kimi K., Baines I.C., Lee T.H., and Rhee S.G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. JBC 275 (2000) 20346-20354
17. Lee S.P., Hwang Y.S., Kim Y.J., Kwon K.S., Kim K., and Chae H.Z. Cyclophilin A binds to peroxiredoxins and activates its peroxidase activity. JBC 276 (2001) 29826-29832
18. Kinnula V.L., Lehtonen S., Kaarteenaho-Wiik R., Lakari E., Paakko P., Kang S.W., Rhee S.G., and Soini Y. Two functional variants of the superoxide dismutase genes in Finnish families with asthma. Thorax 57 (2002) 157-164
19. Wang M.X., Wei A., Yuan J., Trickett A., Knoops B., and Murrell G.A. Expression and regulation of peroxiredoxin 5 in human osteoarthritis. FEBS Lett. 531 (2002) 359-362
20. Plaisant F., Clippe A., Stricht V.D., Knoops B., and Gressens P. Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radical Biol. Med. 34 (2003) 862-872
21. Wang M.X., Wei A., Yuan J., Clippe A., Bernard A., Knoops B., and Murrell G.A. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem. Biophys. Res. Commun. 284 (2001) 667-673
22. Banmeyer I., Marchand C., Verhaeghe C., Vucic B., Rees J.-F., and Knoops B. Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radical Biol. Med. 36 (2004) 65-77
23. Zhou Y., Kok K.H., Chun A.C., Wong C.M., Wu H.W., Lin M.C., Fung P.C., Kung H., and Jin D.Y. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem. Biophys. Res. Commun. 268 (2000) 921-927
24. Mikhailov V.M., Kropotov A.V., Zelenin A.V., Krutilina R.I., Kolesnikov V.A., Zelenina I.A., Baranov A.N., Shtein G.I., Ostapenko O.V., Tomilin N.V., and Baranov V.S. The BCL-xL and ACR-1 genes promote differentiation and reduce apoptosis in muscle fibers of mdx mice. Genetika 38 (2002) 1445-1450
25. Yuan J., Murrell G.A., Trickett A., Landtmeters M., Knoops B., and Wang M.X. Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress. Biochim. Biophys. Acta 1693 (2004) 37-45
26. Kropotov A.V., Grudinkin P.S., Pleskach N.M., Gavrilov B.A., Tomilin N.V., and Zhivotovsky B. Downregulation of peroxiredoxin V stimulates formation of etoposide-induced double-strand DNA breaks. FEBS Lett. 572 (2004) 75-79
27. Ekedahl J., Joseph B., Grigoriev M.Y., Muller M., Magnusson C., Lewensohn R., and Zhivotovsky B. Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells. Exp. Cell Res. 279 (2002) 277-290
28. Fraker P.J., King L.E., Lill-Elghanian D., and Telford W.G. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol. 46 (1995) 57-76
29. Fertil B., and Malaise E.P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int. J. Radiat. Oncol. Biol. Phys. 11 (1985) 1699-1707
30. Joseph B., Ekedahl J., Lewensohn R., Marchetti P., Formstecher P., and Zhivotovsky B. Defective caspase-3 relocalization in non-small cell lung carcinoma. Oncogene 20 (2001) 2877-2888
31. Gogvadze V., Robertson J.D., Zhivotovsky B., and Orrenius S. Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax. J. Biol. Chem. 276 (2001) 19066-19071
32. Schmidt-Mende J., Gogvadze V., Hellstrom-Lindberg E., and Zhivotovsky B. Early mitochondrial alterations in ATRA-induced cell death. Cell Death Differ. 13 (2006) 119-128
33. Karihtala P., Mantyniemi A., Kang S.W., Kinnula V.L., and Soini Y. Peroxiredoxins in breast carcinoma. Clin. Cancer Res. 9 (2003) 3418-3424
34. Mikhailov V.M., Kropotov A.V., Tomilin N.V., Zelenin A.V., Krutilina R.I., Kolesnikov V.A., Ostapenko O.V., Zelenina I.A., Baranov A.N., Shtein G.I., and Baranov V.S. Gene hACR-1 suppresses apoptosis of striated muscle fibres of m. quadriceps femoris after ballistic transfection of mdx mice. Tsitologiia 44 (2002) 374-378
35. Muller I., Niethammer D., and Bruchelt G. Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). Int. J. Mol. Med. 1 (1998) 491-494
36. Minotti G., Menna P., Salvatorelli E., Cairo G., and Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56 (2004) 185-229
37. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57 (1999) 727-741
38. Chen G., Shu J., and Stacey D.W. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Oncogen 15 (1997) 1643-1651
39. Bartling B., Lewensohn R., and Zhivotovsky B. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide. Exp. Cell Res. 298 (2004) 83-95
40. Halestrap A.P., Woodfield K.Y., and Connern C.P. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem. 272 (1997) 3346-3354
41. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341 (1999) 233-249
42. Brodin O., Lennartsson L., and Nilsson S. Single-dose and fractionated irradiation of four human lung cancer cell lines in vitro. Acta Oncol. 30 (1991) 967-974
43. Sirzen F., Zhivotovsky B., Nilsson A., Bergh J., and Lewensohn R. Spontaneous and radiation-induced apoptosis in lung carcinoma cells with different intrinsic radiosensitivities. Anticancer Res. 18 (1998) 695-699
44. Bergh J., Nilsson K., Ekman R., and Giovanella B. Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol. Microbiol. Immunol. Scand. [A] 93 (1985) 133-147
45. Carmichael J., Degraff W.G., Gamson J., Russo D., Gazdar A.F., Levitt M.L., Minna J.D., and Mitchell J.B. Radiation sensitivity of human lung cancer cell lines. Eur. J. Cancer Clin. Oncol. 25 (1989) 527-534
46. Carney D.N., Mitchell J.B., and Kinsella T.J. In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res. 43 (1983) 2806-2811
47. Persson L.M., Lind B.K., Edgren M.R., HedlofI I., and Brahme A. RBE of 50 MV scanned bremsstrahlung beams determined using clonogenic assay. Int. J. Radiat. Biol. 78 (2002) 275-284
48. Morstyn G., Russo A., Carney D.N., Karawya E., Wilson S.H., and Mitchell J.B. Heterogeneity in the radiation survival curves and biochemical properties of human lung cancer cell lines. J. Natl. Cancer Inst. 73 (1984) 801-807